Cargando…
Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial Sarcoma
Synovial sarcoma is an aggressive malignancy that generally affects adolescents and young adults and is characterized by high rates of recurrence and metastasis, with a 10-year survival rate of about 50%. The fusion oncoprotein SS18-SSX, the product of a pathognomonic chromosomal translocation t(X;1...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444294/ https://www.ncbi.nlm.nih.gov/pubmed/35880992 http://dx.doi.org/10.1097/PAI.0000000000001049 |